OGN NYSE

Organon & Co.

Health Care ·Pharmaceutical preparations ·Common Stock
Dividend per share · FY2025$0.34as reported in the 10-K
Latest quarterly dividend$0.02quarter ended 2026-09-30 · filing
FCF cover · FY20256.11x3-year average 2.72x
Consecutive increases0years, within FY2021–FY2025

OGN dividend record

Annual figures as reported in Organon & Co.’s Form 10-K filings with the US SEC. Free cash flow = operating cash flow − capital expenditure. FCF cover = free cash flow ÷ dividends paid. Each row links to its filing. Data as of SEC EDGAR, retrieved 16 Nov 2026.

  • Dividend per share fell 70% in FY2025.
  • Dividend per share rose 100% in FY2022. Large one-year changes can reflect a special dividend, a resumed dividend or a change in payment timing; the 10-K explains which.
  • Dividend per share is the amount declared in each fiscal year, as the company reports it in its 10-K.

Original source: Organon & Co. filings on SEC EDGAR · How we calculate · Report an error

General information only — not financial advice. Share prices and dividend yields are not shown until a licensed price feed is connected.

About Organon & Co.

Organon & Co. is listed on the NYSE under the ticker OGN. The SEC classifies its business as “Pharmaceutical Preparations” (SIC code 2834). Its fiscal year ends in December.

Common Stock >3x